Dec 8, 2025 04:53AM
Sep 17, 2025 01:30PM
Aug 18, 2025 06:16AM
Jul 24, 2025 10:00AM
Mar 20, 2025 12:39PM
Mar 17, 2025 01:08PM
Dec 17, 2024 02:00PM Clear Street Launches Healthcare & Biotechnology Equity Research
Nov 14, 2024 08:33AM
Dec 22, 2023 06:38AM
Dec 22, 2023 06:37AM
Aug 23, 2023 07:52AM
Aug 23, 2023 06:09AM
Jun 15, 2023 04:57AM
Apr 19, 2023 04:02AM Mizuho Securities Upgrades Immuneering Corporation (IMRX) to Buy
Apr 17, 2023 06:02AM
Mar 29, 2023 04:04PM
Mar 29, 2023 04:03PM
Mar 29, 2023 04:03PM
Feb 8, 2023 12:25PM
Dec 2, 2022 06:17AM
Oct 27, 2022 09:01AM Merck (MRK) Pops After Beat-and-raise, Analyst Praises a 'Strong' Beat
Oct 10, 2022 11:02AM
Jul 28, 2022 02:03PM
Jul 7, 2022 04:02AM
Jun 28, 2022 08:18AM
Jun 28, 2022 08:17AM
May 11, 2022 07:45AM
May 3, 2022 07:56AM Mizuho Securities Reiterates Buy Rating, $95 Price Target on Incyte (INCY)
Apr 26, 2022 05:29AM
Apr 14, 2022 08:28AM
Apr 11, 2022 06:44AM
Apr 11, 2022 06:26AM
Apr 11, 2022 05:56AM
Apr 7, 2022 06:09AM
Apr 4, 2022 08:54AM Mizuho Securities Reiterates Buy Rating, $20 PT on eFFECTOR Therapeutics (EFTR) Following CMO Departure, Sees Upcoming Phase IIa zotatifin Data as Key to Pipeline Validation
Mar 31, 2022 06:36AM
Mar 22, 2022 12:04PM
Mar 17, 2022 06:10AM
Mar 14, 2022 07:58AM
Mar 10, 2022 11:03AM
Mar 1, 2022 06:47AM
Feb 24, 2022 06:00AM Mizuho Securities Reiterates Buy Rating on Xencor (XNCR), Sees Multiple Opportunities
Feb 24, 2022 05:34AM
Feb 8, 2022 07:53AM
Feb 3, 2022 08:53AM
Feb 3, 2022 07:59AM
Jan 20, 2022 09:19AM
Jan 18, 2022 05:56AM
Jan 12, 2022 09:31AM Mizuho Americas Hires Graig C. Suvannavejh, PhD, as Senior Biopharmaceuticals and Biotechnology Analyst
Jan 12, 2022 09:31AM

190 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All